TIFFANY ICKIEWICZ: Open Payments
NPI 1902101140 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,982 in 102 payments from 31 companies in 2025. Trend: 2023 $651 · 2024 $1,414 · 2025 $1,982
Food & beverage: $1,982
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $250 |
| ABBVIE INC. | 9 | $177 |
| Lilly USA, LLC | 8 | $153 |
| Madrigal Pharmaceuticals | 6 | $138 |
| Novartis Pharmaceuticals Corporation | 6 | $113 |
| Viatris Specialty LLC | 5 | $90 |
| PFIZER INC. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Boston Scientific Corporation | 4 | $71 |
| Astellas Pharma US Inc | 3 | $66 |
Products named: Ozempic, REZDIFFRA, REXULTI, LEQVIO, YUPELRI, QULIPTA, ELIQUIS, WATCHMAN FLX.
Industry payments across PA — which companies pay providers there.
